Clinical Trial

COmparison of Maintenance of Propofol And Sevoflurane Spectral Study

Study acronym: COMPASS
Recruiting
View on ClinicalTrials.gov →
Summary
Lower EEG alpha band power is currently extensively studied as a potential biomarker of brain vulnerability. No previous study has evaluated whether there was a difference in EEG power spectrum ranges between propofol and sevoflurane, the two main anesthetic agents for maintenance of general anesthesia, in order to define a cut-off value for the prediction of a higher risk of postoperative delirium. * Primary objective: comparison of EEG alpha power (dB) during maintenance of anesthesia with propofol and sevoflurane using data available in the NeuroSense® depth-of-anesthesia monitoring * Secondary objectives: comparison of other EEG frequency bands during maintenance of anesthesia with propofol and sevoflurane using data from the NeuroSense® depth-of-anesthesia monitoring
Trial Details
NCT Number NCT07561970
Lead Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions Electroencephalography/Drug Effects
Enrollment 280 participants
Start Date 2026-04-13
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-01